Stage IIB Non-Small Cell Lung Carcinoma
specificStage IIB includes: (T2b, N1, M0); (T3, N0, M0). T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension. T3: Lung cancer with a tumor size more than 7 cm or one that directly invades any of the following: parietal pleural (PL3) chest wall (including superior sulcus tumors), diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium; or tumor in the main bronchus (less than 2 cm distal to the carina but without involvement of the carina); or associated
13
Centers
0
Active Trials
—
Cancer Funding
Top Centers for Stage IIB Non-Small Cell Lung Carcinoma(13)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive | 53.8 |
| 2 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive | 53.8 |
| 3 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive | 53.8 |
| 4 | NCI Clinical | 53.8 |
| 5 | Medical College of Wisconsin Cancer CenterMilwaukee, WI | 53.8 |
| 6 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical | 53.8 |
| 7 | University of Illinois Cancer CenterChicago, IL | 53.8 |
| 8 | University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical | 53.8 |
| 9 | University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive | 53.8 |
| 10 | Cancer Center at IllinoisUrbana, IL | 53.8 |
| 11 | Georgia Cancer Center, Augusta UniversityAugusta, GA | 53.8 |
| 12 | 53.8 | |
| 13 | Louisiana Cancer Research CenterNew Orleans, LA | 53.8 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →